We are live on
!
Find out more
iBio
IBIO
IBIO
10 hedge funds and large institutions have $393K invested in iBio in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
46% less capital invested
Capital invested by funds: $731K → $393K (-$338K)
50% less funds holding
Funds holding: 20 → 10 (-10)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Holders
10
Holders Change
-10
Holders Change %
-50%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
S
SignatureFD
Atlanta,
Georgia
|
+$208K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$19.7K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$11.3K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$28K |
| 2 |
Bank of New York Mellon
New York
|
-$20K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12.9K |
| 4 |
VF
Virtu Financial
New York
|
-$12K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
